Evidence map›Paper›PMID 33594545›Full record

ArticleWorld journal of microbiology & biotechnology2021

In vitro properties of potential probiotic lactic acid bacteria originating from Ghanaian indigenous fermented milk products.

Grace Adzo Motey, James Owusu-Kwarteng, Kwasi Obiri-Danso, Linda Aurelia Ofori, William Otoo Ellis, Lene Jespersen

Abstract read
PubMed Publisher
In one paragraph

Article in World journal of microbiology & biotechnology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Cold-Adapted Uric Acid-DegradingMolecules (Basel, Switzerland) · 2026
    Article
  3. A One-Health Perspective onEnvironmental health insights · 2026
    Review
  4. Article
  5. Review
  6. Heliyon · 2024
    Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Probiotic potential of3 Biotech · 2022
    Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Grace Adzo MoteyDepartment of Applied Biology, C. K. Tedam University of Technology and Applied Sciences, Navrongo, Ghana. gamotey@gmail.com.ORCID http://orcid.org/0000-0002-6126-5323
James Owusu-KwartengDepartment of Food Science and Technology, University of Energy and Natural Resources, Sunyani, Ghana.
Kwasi Obiri-DansoDepartment of Theoretical and Applied Biology, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Linda Aurelia OforiDepartment of Theoretical and Applied Biology, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
William Otoo EllisDepartment of Food Science and Technology, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Lene JespersenDepartment of Food Science, University of Copenhagen, Rolighedsvej 26, 1958, Frederiksberg C, Denmark.

Funding

Danish International Development Agency DFC No 13-04KU
6 · The paper itself

Abstract

Fermented milk products are a major source of health-promoting microorganisms known as probiotics. To characterize the probiotic properties of lactic acid bacteria isolated from Ghanaian traditionally fermented milk, thirty (30) isolates comprising Enterococcus faecium (1), Lactobacillus fermentum (14), Lb. plantarum (2) and Pediococcus acidilactici (13) identified by 16S rRNA gene sequencing, were tested for survival at low pH (2.5) and bile salts (0.3% (w/v)), hydrophobicity, co-aggregation, auto-aggregation and antimicrobial activities against selected pathogens. Safety of potential probiotic bacteria was assessed by hemolytic activity on blood agar and susceptibility to nine different antibiotics. Majority (90%) of the strains showed survival rates above 80% at pH (2.5) and in bile salts (0.3% (w/v)). Hydrophobicity ranged from 5 to 61% while cell auto-aggregation ranged from 41 to 80% after 24 h. Co-aggregation with E. coli (3.7-43.9%) and S. Typhimurium (1.3-49.5%) were similar for the LAB strains at 24 h. Cell- free supernatants of all LAB strains inhibited E. coli while S. Typhimurium was not sensitive to cell-free supernatants of five Pd. acidilactici strains: OS24h20, OS18h3, OY9h19, OS9h8 and 24NL38. None of the LAB strains showed β-hemolysis but 38% of strains showed α-hemolysis. Susceptibilities to antibiotics were strain-specific; only four strains, two Lb. fermentum and two Pd. acidilactici were susceptible to all nine antibiotics tested. Based on high survival rates in bile salts, low pH and generally good hydrophobicity, auto-aggregation, co-aggregation and inhibitory activities, 15 out of 30 strains tested were considered qualified candidates for development of probiotic cultures for fermented milk products in sub-Saharan Africa.

Indexed as

AnimalsAnti-Bacterial AgentsBile Acids and SaltsCultured Milk ProductsDrug ToleranceEscherichia coliFermentationGhanaHydrogen-Ion ConcentrationLactobacillalesMilkProbioticsRNA, Ribosomal, 16SAnti-Bacterial AgentsBile Acids and SaltsRNA, Ribosomal, 16SAntibiotic resistanceFermented milkLactic acid bacteriaProbiotic characteristics

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.